111 related articles for article (PubMed ID: 2983866)
1. Antitumor activity of protein A administered intravenously to pet cats with leukemia or lymphosarcoma.
Harper HD; Sjöquist J; Hardy WD; Jones FR
Cancer; 1985 May; 55(9):1863-7. PubMed ID: 2983866
[TBL] [Abstract][Full Text] [Related]
2. Lymphosarcoma and persistent feline leukemia virus infection of pet cats: a system to study responses during extracorporeal treatments.
Jones FR; Grant CK; Snyder HW
J Biol Response Mod; 1984; 3(3):286-92. PubMed ID: 6086847
[TBL] [Abstract][Full Text] [Related]
3. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response.
Snyder HW; Reed DE; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A.
Engelman RW; Tyler RD; Trang LQ; Liu WT; Good RA; Day NK
Am J Pathol; 1985 Mar; 118(3):367-78. PubMed ID: 2983560
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of the feline leukemia virus (FeLV).
Hardy WD; McClelland AJ; MacEwen EG; Hess PW; Hayes AA; Zuckerman EE
Cancer; 1977 Apr; 39(4 Suppl):1850-5. PubMed ID: 192437
[TBL] [Abstract][Full Text] [Related]
6. Development of virus non-producer lymphosarcomas in pet cats exposed to FeLv.
Hardy WD; McClelland AJ; Zuckerman EE; Snyder HW; MacEwen EG; Francis D; Essex M
Nature; 1980 Nov; 288(5786):90-2. PubMed ID: 6253821
[TBL] [Abstract][Full Text] [Related]
7. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70.
Snyder HW; Singhal MC; Hardy WD; Jones FR
J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496
[TBL] [Abstract][Full Text] [Related]
8. Biological effects of staphylococcal protein A immunotherapy in cats with induced feline leukemia virus infection.
Lafrado LJ; Mathes LE; Zack PM; Olsen RG
Am J Vet Res; 1990 Mar; 51(3):482-6. PubMed ID: 1690524
[TBL] [Abstract][Full Text] [Related]
9. Clearance of retroviremia and regression of malignancy in cats with leukemia-lymphoma during treatment with staphylococcal protein A.
Engelman RW; Good RA; Day NK
Cancer Detect Prev; 1987; 10(5-6):435-44. PubMed ID: 3032440
[TBL] [Abstract][Full Text] [Related]
10. Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma.
Hoover EA; Krakowka S; Cockerell GL; Mathes LE; Olsen RG
Am J Vet Res; 1978 Jun; 39(6):993-5. PubMed ID: 208436
[TBL] [Abstract][Full Text] [Related]
11. The management of feline lymphosarcoma.
Loar AS
Vet Clin North Am Small Anim Pract; 1984 Nov; 14(6):1299-330. PubMed ID: 6097009
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats.
Day NK; O'Reilly-Felice C; Hardy WD; Good RA; Witkin SS
J Immunol; 1980 Dec; 125(6):2363-6. PubMed ID: 6253567
[TBL] [Abstract][Full Text] [Related]
13. Feline leukemia virus detection by immunohistochemistry and polymerase chain reaction in formalin-fixed, paraffin-embedded tumor tissue from cats with lymphosarcoma.
Jackson ML; Haines DM; Meric SM; Misra V
Can J Vet Res; 1993 Oct; 57(4):269-76. PubMed ID: 8269365
[TBL] [Abstract][Full Text] [Related]
14. Biology of feline leukemia virus in the natural environment.
Hardy WD; Hess PW; MacEwen EG; McClelland AJ; Zuckerman EE; Essex M; Cotter SM; Jarrett O
Cancer Res; 1976 Feb; 36(2 pt 2):582-8. PubMed ID: 175919
[TBL] [Abstract][Full Text] [Related]
15. Appearance of cytotoxic antibody to viral gp70 on feline lymphoma cells (FL-74) in cats during ex vivo immunoadsorption therapy: quantitation, characterization, and association with remission of disease and disappearance of viremia.
Liu WT; Engelman RW; Trang LQ; Hau K; Good RA; Day NK
Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3516-20. PubMed ID: 6328520
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for feline leukemia, using staphylococcal protein A or heterologous interferons: immunopharmacologic actions and potential use.
Weiss RC
J Am Vet Med Assoc; 1988 Mar; 192(5):681-4. PubMed ID: 2453494
[No Abstract] [Full Text] [Related]
17. [Clinical aspects of infection with feline leukemia virus in cats].
Theilen GH
Tierarztl Prax; 1984; 12(4):511-22. PubMed ID: 6098972
[TBL] [Abstract][Full Text] [Related]
18. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat.
Cotter SM; Hardy WD; Essex M
J Am Vet Med Assoc; 1975 Mar; 166(5):449-54. PubMed ID: 163223
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation therapy for feline leukemia virus infection.
McCaw DL; Boon GD; Jergens AE; Kern MR; Bowles MH; Johnson JC
J Am Anim Hosp Assoc; 2001; 37(4):356-63. PubMed ID: 11450836
[TBL] [Abstract][Full Text] [Related]
20. No benefit of therapeutic vaccination in clinically healthy cats persistently infected with feline leukemia virus.
Helfer-Hungerbuehler AK; Spiri AM; Riond B; Grest P; Boretti FS; Hofmann-Lehmann R
Vaccine; 2015 Mar; 33(13):1578-85. PubMed ID: 25698488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
